MTOR and hepatocellular carcinoma: Collectively, these findings suggest that the activation of the IGF1R/AKT/mTOR signaling pathway not only reverses the inhibitory influence of Let‐7b‐5p on cell proliferation but also promotes the malignant progression of HCC.